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Lupeol, which shows in vitro inhibitory activity against Plasmodium falciparum 3D7 strain with a 50% inhibitory
concentration (IC50) of 27.7 0.5M, was shown to cause a transformation of the human erythrocyte shape toward
that of stomatocytes. Good correlation between the IC50 value and the membrane curvature changes caused by
lupeol was observed. Preincubation of erythrocytes with lupeol, followed by extensive washing, made the cells
unsuitable for parasite growth, suggesting that the compound incorporates into erythrocyte membrane irreversibly.
On the other hand, lupeol-treated parasite culture continued to grow well in untreated erythrocytes. Thus, the
antiplasmodial activity of lupeol appears to be indirect, being due to stomatocytic transformation of the host cell
membrane and not to toxic effects via action on a drug target within the parasite. A number of amphiphiles that
cause stomatocyte formation, but not those causing echinocyte formation, were shown to inhibit growth of the
parasites, apparently via a mechanism similar to that of lupeol. Since antiplasmodial agents that inhibit parasite
growth through erythrocyte membrane modifications must be regarded as unsuitable as leads for development of
new antimalarial drugs, care must be exercised in the interpretation of results of screening of plant extracts and
natural product libraries by an in vitro Plasmodium toxicity assay.
Malaria continues to be a growing health problem of global
dimensions. According to World Health Organization estima-
tions, the number of clinical cases has reached 300 to 500
million per year, most of which are in sub-Saharan Africa.
Increased geographical spreading of the disease is observed,
mainly in Asia. In addition to a mortality rate of 1.1 to 2.7
million deaths per year (27), mostly among children, malaria
puts a heavy economic burden on the developing world by
exhausting health system resources and by associated loss of
economic activity. Only a limited number of chemotherapeutic
agents for the treatment of malaria are available, and the
growing problem of drug resistance makes adequate treatment
of malaria increasingly difficult (27).
In the absence of a functional, safe, and widely available
malaria vaccine, efforts to develop new antimalarial drugs are
profoundly important. Since the vast majority of the existing
antimalarial chemotherapeutic agents are based on natural
products (3, 4), biological chemodiversity continues to play an
important role in the search for leads for antimalarial drugs.
Research aiming at drug discovery and the development of
novel antimalarial agents depends critically on in vitro toxicity
assays employing various Plasmodium strains, pioneered by Des-
jardins et al. (6). As with any cellular in vitro assay, the Plasmo-
dium assay should be fast, robust, and not prone to artifacts.
Ideally, an assay should be able to identify drugs that specifically
interfere with the parasite biochemistry. However, since the Plas-
modium parasites are cultured in erythrocytes, their growth may
be influenced indirectly by drug effects on the host cell. Because
Plasmodium parasites depend on the function of the erythrocyte
membrane by changing its permeability and opening nutrient
uptake channels (5), alterations of membrane properties are
likely to interfere with the parasite growth. This may happen
generally with surface-active (amphiphilic) compounds and other
lipophilic compounds that can be incorporated into the lipid bi-
layer. In this work we describe a correlation between changes of
the erythrocyte membrane shape observed microscopically and
the inhibition of Plasmodium falciparum growth caused by lupeol
(Fig. 1), a natural product isolated as the principal in vitro anti-
plasmodial agent from the extract of a tropical plant Rinorea
ilicifolia Kuntze (plant family Violaceae). Similar results were ob-
tained with a series of synthetic amphiphiles. The indirect anti-
plasmodial activity, hardly of any interest in a search for new
antimalarial drugs, must be taken into account when the results of
in vitro drug sensitivity assays based on Plasmodium cultures
grown in erythrocytes are assessed.
MATERIALS AND METHODS
Chemicals. Authentic lupeol, N-cetyl-N,N,N-trimethylammonium bromide
(compound 5), chlorpromazine hydrochloride (compound 11), and chloroquine
diphosphate were purchased from Sigma Chemical Co. Zwittergents [3-(alky-
ldimethylammonio)-1-propanesulfonates (compounds 3 and 4)] and decyl--D-
glucopyranoside (compound 7) were obtained from Calbiochem-Behring, and
sodium alkyl sulfates (compounds 1 and 2) were obtained from Merck. Hexa-
decylpyridinium bromide (compound 6), octaethyleneglycol monoalkyl ethers
(compounds 8 and 9), and pentaethyleneglycol monododecyl ether (compound
10) were from Fluka. All chemicals were reagent grade and were used as re-
ceived. Column-chromatographic separations were performed on Matrex silica
gel 60A (37 to 70 m; Millipore). [2,3,4,5,6-3H]phenylalanine was obtained from
Amersham Pharmacia Biotech, and the solution was diluted to 1.6 MBq/ml with
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saline. Growth media and auxiliary chemicals for parasite cultivation were pur-
chased from Gibco-BRL.
Assay for antiplasmodial activity. A modification of Desjardins’ radioisotope
method (6) for measuring the growth of a chloroquine-sensitive strain of P.
falciparum (3D7) was adopted, with incorporation of [3H]phenylalanine as an
index of growth (11). Thus, 50 l of the growth medium (RPMI 1640 with
HEPES and supplemented with 0.45% Albumax II, 1.42 mM L-glutamine, 133
M hypoxanthine, and 44 mg of gentamicin sulfate/ml) containing test sub-
stances added from a dimethyl sulfoxide (DMSO) stock (lupeol) or a water stock
(amphiphiles) was mixed with 50 l of a suspension of parasitized erythrocytes
(blood type, O; hematocrit, 5%; parasitemia, 2 to 3%) in 96-well microtiter
plates. The maximum final concentration of DMSO in the growth medium was
0.5%; reference wells contained DMSO in the concentration range of 0 to 0.5%.
Each concentration of the test substances was tested in duplicate. The plates
were incubated at 37°C for 24 h in an atmosphere consisting of 93% N2, 5% CO2,
and 2% O2; [3H]phenylalanine solution (25 l, 1.6 MBq/ml) was added, and the
incubation was continued for 24 h. The cells were harvested on filter plates
(Packard UniFilter GF/C) with Packard Cell Harvester (FilterMate 96-well
model) by using distilled water as a wash medium, and 20 l of scintillation fluid
(Microscint-O) was added to each filter well. The incorporation of activity was
measured by using a TopCount Packard Microplate Scintillation Counter. The
50% inhibitory concentration (IC50) values were derived from the radioactivity
counts by nonlinear curve fitting with GraFit program (version 4.06) from Er-
ithacus Software, Ltd., by using a four-parameter logistic equation. Chloroquine
was used as a reference in all determinations. Each assay was repeated at least
twice (n  2).
Erythrocyte membrane shape changes caused by lupeol. Normal and parasit-
ized erythrocytes were incubated in medium containing various amounts of
lupeol (3.13 to 200 g/ml) or DMSO in the concentration range from 0 to 2% as
described above, but omitting addition of [3H]phenylalanine. After 48 h of
incubation, the plate was placed on a shaking table for 1 min, and 20-l samples
were spread on microscope slides, allowed to dry, fixed with methanol, and
stained with Giemsa for phase-contrast light microscopy. For transmission elec-
tron microscopy, 100-l samples were transferred into Eppendorf tubes and
treated with 5 l of 25% aqueous glutaric aldehyde for at least 1 h. A fraction (5
l) of this suspension was used for light-microscopic determination of the eryth-
rocyte shape in a hanging drop. The cells were washed three times with 0.1 M
sodium phosphate buffer (pH 7.4). After postfixation with osmium tetroxide (a
1:1 mixture of 2% aqueous OsO4 and 0.3 M sodium phosphate buffer [pH 7.4])
for 1 to 2 h and repeated washing with phosphate buffer, the cells were dehy-
drated by a series of acetone washes and embedded in Epon. The samples were
cut in 50- to 60-nm-thick sections, stained with lead citrate and then with uranyl
acetate, and examined with a JEOL 100SX electron microscope.
Parasite growth in erythrocytes pretreated with lupeol. Solutions of lupeol in
0.4 ml of DMSO were mixed with 38.6 ml of RPMI 1640 medium (containing all
additives) and 1 ml of packed human erythrocytes (1010 cells), and the suspensions
(final hematocrit of 2.5%) were placed in 80-cm2 flasks and incubated for 48 h at
37°C (93% N2, 5% CO2, and 2% O2). The final concentration of lupeol was 25 or
100g/ml; reference flasks contained the same amount of DMSO but no lupeol. The
erythrocytes were separated (2,000 rpm for 10 min) and washed four times with the
medium in order to remove dissolved lupeol. The process was monitored micro-
scopically to ensure that no cell shape alterations occurred during this procedure.
The cells were then used for subcultivation of P. falciparum in 25-cm2 flasks. Thus,
200 l of the erythrocytes obtained as described above was mixed with 20 l of
infected erythrocytes (parasitemia 5%) and incubated with 5 ml of the RPMI
medium. The growth medium was replaced with a fresh portion every 48 h. Every 2
to 3 days a sample of erythrocytes was withdrawn, and parasite counts were deter-
mined microscopically, counting three microscope fields (n 3, 100 erythrocytes per
field). When parasitemia reached 5%, the culture was subcultured similarly as
described above by using 5 l of the culture.
Growth of lupeol-treated parasites in untreated erythrocytes. Solutions of
lupeol in 50 l of DMSO were mixed with 5 ml of RPMI 1640 medium (con-
taining all additives) and 100 l of parasitized erythrocytes (parasitemia 5.4%),
and the suspensions (final hematocrit 2.5%) were placed in 25-cm2 flasks and
incubated for 3 or 6 h as described above. The final concentration of lupeol was
25 or 100 g/ml; reference flasks contained the same amount of DMSO but no
lupeol. The erythrocytes were separated and washed as described previously in
order to remove all traces of lupeol. The process was evaluated microscopically
to monitor the cell shape. The parasitized cells thus obtained were subcultured
with untreated erythrocytes. The growth medium was replaced with a fresh
portion every 48 h. A sample of erythrocytes was withdrawn every day, and
parasite counts were determined microscopically, counting three microscope
fields (n  3, 100 erythrocytes per field), until parasitemia reached 5%.
Isolation of lupeol from R. ilicifolia Kuntze. Plant material was collected in
Ghana and was identified by D. K. Abbiw, Department of Botany, University of
Ghana. Voucher specimen (GC47600) was deposited in the Ghana Herbarium
(Department of Botany, University of Ghana, Legon, Ghana). Finely ground
branches (258 g) were degreased for 2 h in a Soxhlet apparatus with 1.5 liter of
light petroleum (boiling point, 40 to 65°C) and then extracted three times by
overnight soaking in 1 liter of 96% ethanol. The ethanol extracts were combined
and evaporated to dryness, and the residue (9.6 g) was distributed between ethyl
acetate and water. Evaporation gave 2.2 g of the residue from the ethyl acetate
fraction and 6.0 g from the aqueous fraction. Antiplasmodial activity was asso-
ciated solely with the ethyl acetate fraction (IC50  12 g/ml). This material was
chromatographed on a 2- by-72-cm silica gel column (170 g of silica) by using a
step gradient of ethyl acetate in dichloromethane, collecting 25-ml fractions
which were monitored by thin-layer chromatography and by P. falciparum growth
inhibition assay. The most active fractions, eluted with 3% ethyl acetate, yielded
62 mg (0.024% of the plant material used) of lupeol, as identified by comparison
of its 400-MHz 1H and 100.6-MHz 13C nuclear magnetic resonance spectra in
CDCl3 with those of authentic lupeol.
RESULTS
Lupeol as apparent antiplasmodial constituent of R. ilicifo-
lia. In a screening of plants for antiplasmodial activity, extracts
of R. ilicifolia completely inhibited the incorporation of
FIG. 1. Chemical structure of lupeol.
TABLE 1. Apparent in vitro inhibitory activity of lupeol and model
amphiphiles on the growth of P. falciparum 3D7 and the effect
of the compounds on human erythrocyte shape
Compounda Netcharge
Mean IC50 (M) 
spread (n  2)
Effect on erythro-
cyte shapeb
Lupeol 0 27.7  0.5 Stomatocytogenic
1 1 460  17 Echinocytogenic
2 1 145c Echinocytogenic
3 0 782  140 Echinocytogenic
4 0 65d Echinocytogenic
5 1 20.5  1.9 Stomatocytogenic
6 1 1.4  0.17 Stomatocytogenic
7 0 233  13 Stomatocytogenic f
8 0 54.6  7.8 Stomatocytogenic
9 0 33.1  2.6 Stomatocytogenic
10 0 67.7  2.7 Stomatocytogenic
11 1 27.9  2.6 Stomatocytogenic
Chloroquine 2 0.045  0.004 Nonee
a Compounds 1 to 11 correspond to the numbered structures in Fig. 4.
b Data for compounds 1 to 11 are from references 13 and 18.
c There was practically no inhibition at this concentration, which is the solu-
bility limit of the compound in the medium.
d There was practically no inhibition at this concentration; lysis of erythrocytes
occurs at higher concentrations.
e No effect on membrane shape at active concentrations (2 M) was ob-
served (this study); the compound is stomacytogenic at millimolar concentrations
(22).
f Weakly.
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FIG. 2. Effect of lupeol on human erythrocyte shape. (A) Control. (B) Erythrocytes treated with 2% DMSO. (C and D) Erythrocytes treated
with 50 g of lupeol/ml (117.2 M). (E) Erythrocytes treated with 12.5 g of lupeol/ml (29.3 M). (F) Erythrocytes treated with 3.13 g of
lupeol/ml (7.3 M). Micrographs A to C were obtained with a light microscope (	800), with a sample fixed with glutaric aldehyde (final
concentration, 1%) and sealed between glass slides in order to prevent the sample from drying. Micrographs D to F were obtained with a
transmission electron microscope (	10,000).
VOL. 46, 2002 IN VITRO PLASMODIUM FALCIPARUM ASSAY 1443
[3H]phenylalanine into the chloroquine-sensitive 3D7 strain of
P. falciparum at 12 g/ml. Bioactivity-guided fractionation
identified the triterpene lupeol (Fig. 1) as the major agent
responsible for the activity, with an apparent IC50 value of 11.8
g/ml or 27.7 M (Table 1) obtained with purified material.
After lupeol was identified as the antiplasmodial agent of R.
ilicifolia extracts, all subsequent experiments were carried out
with commercial samples of lupeol.
Effect of lupeol on erythrocyte membrane. Microscopic ex-
amination of a parasite culture incubated with lupeol showed
concentration-dependent changes of erythrocyte shape. No ly-
sis of the cells was observed, but the shape of erythrocytes was
altered toward stomatocytic forms. The changes were very
pronounced at lupeol concentrations of50 g/ml (117.2 M)
(Fig. 2) but could also be observed at concentrations as low as
3.13 g/ml (7.3 M). Consistent findings were obtained by
various methods of sample fixation, and thus the changes in
erythrocyte shape were not induced by sample preparation.
Progressive changes in erythrocyte shape were observed by
transmission electron microscopy to be a function of concen-
tration (Fig. 2). Based on the nomenclature of Bessis (2), the
dominant erythrocyte shapes were the normal discocytes at
lupeol concentrations of 3.13 g/ml (7.3 M), which changed
to spherostomatocytes at 12.5 to 200 g/ml (29.3 to 468.7 M).
At the lowest lupeol concentration (3.13 g/ml), only a few
stomatocytes of type 1 (S1) were observed. At 6.25 g of
lupeol/ml (14.6 M) discocytes were still present, but stomato-
cytes of type 2 (S2) predominated. At 12.5 g/ml, a few S1
were seen, but spherostomatocytes (SS) were the dominant
shape. Only SS forms were seen at higher concentrations (25 to
200 g/ml, 58.6 to 468.7 M). Thus, the changes of erythrocyte
membrane curvature occur at concentrations corresponding to
and below the apparent IC50 value of lupeol. As a result of
stomatocytosis lupeol induced endovesiculation, and the num-
ber as well as the size of the vesicles increased with increasing
lupeol concentration (Fig. 2). The vesicles were located mainly
along the erythrocyte membrane. Parasites observed inside the
lupeol-treated erythrocytes were fewer in number and much
smaller than those observed inside untreated erythrocytes.
DMSO at concentrations up to 2% caused no changes in eryth-
rocyte shape (Fig. 2). The effect of lupeol on erythrocyte shape
did not depend on whether the cells contained the parasites or
not. No effect on erythrocyte shape was observed with chloro-
quine in the concentration range that caused complete inhibi-
tion of parasite growth.
Effect of pretreatment of erythrocytes with lupeol on the
growth of P. falciparum. When parasites were cultured in eryth-
rocytes pretreated with lupeol and extensively washed prior to
cultivation, severe impairment of growth was observed (Fig. 3).
Thus, when parasitized erythrocytes (parasitemia, 5%) were
mixed with erythrocytes exposed to 25 g of lupeol/ml (58.6
M), all forms of the parasites were observed only during the
first 3 days of cultivation. In the culture with erythrocytes
pretreated with 100 g of lupeol/ml (234.4 M), mainly tro-
phozoites were observed during the first days. There appears to
be a slight increase of parasitemia from day 3 to day 5 in both
cultures. After an additional 2 days, most of the parasites were
extracellular, and no live parasites were observed from day 10
in either culture (the medium was replaced regularly). Culture
with erythrocytes pretreated with 100 g of lupeol/ml con-
tained more extracellular parasites than that pretreated with
25 g/ml, and both cultures showed an excess of ruptured
schizonts and merozoites compared to the control. On the
other hand, parasites cultured with erythrocytes pretreated in
the identical way but without lupeol present exhibited normal
growth, reaching 5% parasitemia on day 5, after which they
were subcultured with the same batch of erythrocytes and
continued to grow normally. This experiment demonstrates
that exposure to lupeol caused permanent changes of erythro-
cytes that made them unsuitable as parasite host cells even in
the absence of lupeol in the growth medium. Normal growth of
parasites in the cells pretreated the same way but in the ab-
FIG. 3. (Top panel) Growth of P. falciparum 3D7 in erythrocytes preincubated with 100 g (234.4 M) and 25 g (58.6 M) of lupeol/ml and
in erythrocytes preincubated in an identical way but in the absence of lupeol (control). The control was subcultured on day 5. (Bottom panel)
Growth in untreated erythrocytes of P. falciparum 3D7 preincubated with lupeol. The parasite cultures were pretreated with 25 g (58.6 M) or
100 g (234.4 M) of lupeol/ml for 3 or 6 h and then subcultured with fresh erythrocytes.
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sence of lupeol ensured that erythrocytes were not damaged
during the washing procedure. The latter conclusion was sup-
ported by the microscopic examination of the cell shapes.
Effect of pretreatment with lupeol on parasite growth in
untreated erythrocytes. When erythrocytes were incubated for
3 or 6 h with 25 or 100 g of lupeol/ml (58.6 or 234.4 M), the
culture showed stomatocytic cell shape, whereas normal disco-
cytic shapes were observed with the control cells. When the
cultures were subcultured with fresh, untreated erythrocytes,
all cultures continued to grow at the same rate, regardless of
whether they were pretreated with lupeol or not (Fig. 3). All of
the cultures contained all parasite stages. Thus, a sublethal
preincubation of parasites with lupeol did not affect their abil-
ity to invade and multiply in untreated erythrocytes.
Effect of amphiphiles on parasite growth. A number of syn-
thetic amphiphiles (structures 1 to 10 in Fig. 4) known to
induce changes in erythrocyte shape (18) were tested for inhi-
bition of P. falciparum growth in the in vitro assay. Chlorprom-
azine (structure 11 in Fig. 4), a standard stomatocytogenic
compound (18), was included in the study as a reference. The
results are shown in Table 1. There appears to be a good
correlation between the in vitro activity of the amphiphiles and
the type of membrane shape change induced, with the sto-
matocytogenic amphiphiles being far more potent antiplasmo-
dial agents than the echinocytogenic amphiphiles.
DISCUSSION
It is well known that erythrocytes respond to various treat-
ments by changing their shape. Echinocytes are produced by
forces that cause evagination, whereas stomatocytes are pro-
duced by forces that produce invagination of the cellular mem-
brane (9, 16, 23). A variety of amphiphilic agents have been
shown to induce echinocytic or stomatocytic shapes of eryth-
rocytes (7, 10, 18). These shape transformations are thought to
depend mainly on the distribution of the amphiphile in the
bilayer, i.e., whether the amphiphile is predominantly incorpo-
rated into the outer or the inner membrane leaflet. This leads
to expansion of one leaflet relative to the other. In the case of
charged amphiphiles, there is a correlation between the charge
and the membrane shape change effect, presumably governed
by electrostatic interactions with negatively charged phospho-
lipids present mainly in the inner leaflet (15). For neutral
amphiphiles, no clear structure-activity relationships have
emerged. Moreover, amphiphiles at low (sublytic) concentra-
tions protect erythrocytes against hypotonic hemolysis (17, 19).
The incorporation of amphiphiles into the erythrocyte mem-
brane was also observed directly by using radioactive tracers
(14). There is thus considerable knowledge regarding the
changes in erythrocyte membrane shape caused by amphi-
philes and concentration regions at which these changes occur.
Using a series of amphiphiles (Fig. 4) previously shown to
alter the shape of erythrocytes, we found that forces causing
stomatocytic, but not echinocytic, changes of erythrocyte mem-
brane make the cells unsuitable as P. falciparum hosts. Thus,
stomatocytogenic compounds were shown to act generally as in
vitro antiplasmodial agents with moderate to high activity
(IC50 values in the range of 1.4 to 68 M; Table 1). Echino-
cytogenic compounds were only active at much higher concen-
trations (IC50  460 M; Table 1). Alterations of the eryth-
rocyte shape were also observed with lupeol (Fig. 1), the major
antiplasmodial constituent isolated from the plant R. ilicifolia.
It has previously been described that lupeol exhibits inhibitory
activity on P. falciparum growth in vitro but lacks in vivo ac-
tivity in mice infected with P. berghei (1). However, no infor-
mation about the mechanism of the in vitro activity was re-
ported. It is now shown that lupeol causes membrane shape
changes of erythrocytes toward stomatocytic forms observable
at concentrations below its IC50 value. The compound induced
endovesiculation, which is characteristic of stomatocytogenic
FIG. 4. Structures of amphiphilic compounds 1 to 11 tested for antiplasmodial activity in vitro.
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compounds (13). There is a good correlation between the
lupeol concentration at which morphological changes in eryth-
rocytes occur and the observed IC50 of this compound (Fig. 1
and Table 1). This strongly suggests that the in vitro antiplas-
modial activity of lupeol is indirect, being due to membrane
modification of the host cell.
The structure of lupeol is reminiscent of that of cholesterol,
and the compound is expected to be able to enter the cellular
membranes. Due to the presence of a single hydroxy group and
a large, apolar skeleton (Fig. 1), lupeol acts as an amphiphile.
According to the bilayer hypothesis (24, 25), stomatocytes are
generally formed when a lipophilic compound is incorporated
into and expands the inner layer of the lipid membrane. Such
changes appear to be more prohibiting with respect to parasite
growth than incorporation of an amphiphile into the outer
layer, as in case of echinocytogenic compounds (Table 1).
We demonstrated that the inhibition of parasite growth does
not require the presence of lupeol in the growth medium, since
erythrocytes preincubated with lupeol proved to be unsuitable
for parasite cultivation (Fig. 3). This strongly suggests the per-
manent incorporation of lupeol into the lipid bilayer. The
presence of an excess of extracellular merozoites in a culture
employing erythrocytes pretreated with lupeol suggests that
the invasion of the erythrocytes has been impaired also.
In an inverse experiment relative to that described above, a
parasite culture was treated with lupeol and subcultured with
untreated erythrocytes (Fig. 3). In this experiment, the time of
preincubation had to be limited to 3 to 6 h; otherwise, the
parasites would die. In spite of the pretreatment with lupeol,
the parasites grew normally in untreated cells after removal of
lupeol (Fig. 3). Thus, the ability of the parasites to invade and
grow in fresh erythrocytes was not impaired by the initial ex-
posure to lupeol.
Previous studies have demonstrated that alterations of
the erythrocyte membrane such as cross-linking of spectrin,
changes in deformability, spherocytosis, and modification of
the cytoskeletal proteins have inhibitory effects on invasion (8,
11, 20, 21). To our knowledge, no studies of incorporation of
lupeol into erythrocytes and its effect on parasite proliferation
have been reported prior to this work. A recent report of
Vidaya et al. (26) showing that erythrocytes of rats fed with
lupeol exhibit altered osmotic fragility is compatible with our
findings.
Although the exact mechanism by which stomatocytosis
makes the erythrocytes unfavorable for P. falciparum invasion
and growth has yet to be elucidated, the present findings are of
interest for drug discovery programs based on natural prod-
ucts. Lupeol and other pentacyclic triterpenes and sterols with
related structures are very common constituents of plants and
are thus frequently encountered in plant extracts used for
screening. Many synthetic drug candidates may also act as
stomatocytogenic amphiphiles. The membrane alterations that
inhibit parasite growth take place long before they can be
detected by routine examination by optical microscopy (Fig. 2),
and thus care has to be exercised when P. falciparum in vitro
growth inhibition results are interpreted.
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